Skip to main content

Home/ Cancer/ Group items tagged NIH

Rss Feed Group items tagged

Matti Narkia

MedlinePlus: Stem Cells - 0 views

  •  
    Stem cells are cells with the potential to develop into many different types of cells in the body. They serve as a repair system for the body. There are two main types of stem cells: embryonic stem cells and adult stem cells. Doctors and scientists are excited about stem cells because they have potential in many different areas of health and medical research. Studying stem cells may help explain how serious conditions such as birth defects and cancer come about. Stem cells may one day be used to make cells and tissues for therapy of many diseases, including Parkinson's disease, Alzheimer's disease, spinal cord injury, heart disease, diabetes and arthritis.
Vortege Ville

NIH study finds broad spectrum of cancer risk for organ transplant recipients in US - 0 views

  •  
    Organ transplant recipients in the United States have a high risk of developing 32 different types of cancer, according to a new study.
Matti Narkia

Amelioration of cisplatin induced nephrotoxicity in mice by ethyl acetate extract of a ... - 0 views

  •  
    Amelioration of cisplatin induced nephrotoxicity in mice by ethyl acetate extract of a polypore fungus, Phellinus rimosus.\nAjith TA, Jose N, Janardhanan KK.\nJ Exp Clin Cancer Res. 2002 Jun;21(2):213-7.\nPMID: 12148580
Matti Narkia

White button mushroom (Agaricus bisporus) exhibits...[Nutr Cancer. 2008] - PubMed Result - 0 views

  •  
    White button mushroom (Agaricus bisporus) exhibits antiproliferative and proapoptotic properties and inhibits prostate tumor growth in athymic mice. Adams LS, Phung S, Wu X, Ki L, Chen S. Nutr Cancer. 2008;60(6):744-56. PMID: 19005974
Matti Narkia

Ginkgo biloba extract EGb(R)761 exerts anti-angiogenic effects via activation of tyrosi... - 0 views

  •  
    Ginkgo biloba extract EGb(R)761 exerts anti-angiogenic effects via activation of tyrosine phosphatases. Koltermann A, Liebl J, Fürst R, Ammer H, Vollmar AM, Zahler S. J Cell Mol Med. 2008 Oct 23. [Epub ahead of print] PMID: 19175691
Matti Narkia

Mortality and cancer incidence in cohorts of Swedish fishermen and fishermen's wives: u... - 0 views

  •  
    Mortality and cancer incidence in cohorts of Swedish fishermen and fishermen's wives: updated findings.\nMikoczy Z, Rylander L.\nChemosphere. 2009 Feb;74(7):938-43. Epub 2008 Nov 28.\nPMID: 19041115
Matti Narkia

Silibinin synergizes with mitoxantrone to inhibit cell growth and induce apoptosis in h... - 0 views

  •  
    Flaig TW, Su LJ, Harrison G, Agarwal R, Glode LM. Silibinin synergizes with mitoxantrone to inhibit cell growth and induce apoptosis in human prostate cancer cells. Int J Cancer. 2007 Jan 17; [Epub ahead of print] PMID: 17230508 [PubMed - as supplied
Matti Narkia

A phase I and pharmacokinetic study of silybin-phytosome in prostate cancer patients. -... - 0 views

  •  
    Flaig TW, Gustafson DL, Su LJ, Zirrolli JA, Crighton F, Harrison GS, Pierson AS, Agarwal R, Glode LM. A phase I and pharmacokinetic study of silybin-phytosome in prostate cancer patients. Invest New Drugs. 2007 Apr;25(2):139-46. Epub 2006 Nov 1. PMID
Matti Narkia

Prostate cancer chemoprevention by silibinin: bench to bedside. - Entrez PubMed - 0 views

  •  
    Singh RP, Agarwal R. Prostate cancer chemoprevention by silibinin: bench to bedside. Mol Carcinog. 2006 Jun;45(6):436-42. Review. PMID: 16637061 [PubMed - indexed for MEDLINE]
Matti Narkia

Prostate cancer prevention by silibinin. - Entrez PubMed - 0 views

  •  
    Singh RP, Agarwal R. Prostate cancer prevention by silibinin. Curr Cancer Drug Targets. 2004 Feb;4(1):1-11. Review. PMID: 14965263 [PubMed - indexed for MEDLINE]
Matti Narkia

Zyflamend((R))-Mediated Inhibition of Human Prostate Cancer PC3 Cell Proliferation: Eff... - 0 views

  •  
    Yang P, Cartwright C, Chan D, Vijjeswarapu M, Ding J, Newman RA. Zyflamend((R))-Mediated Inhibition of Human Prostate Cancer PC3 Cell Proliferation: Effects on 12-LOX and Rb Protein Phosphorylation. Cancer Biol Ther. 2007 Feb 25;6(2) [Epub ahead of pr
Matti Narkia

Zyflamend, a unique herbal preparation with nonselective COX inhibitory activity, induc... - 0 views

  •  
    Bemis DL, Capodice JL, Anastasiadis AG, Katz AE, Buttyan R. Zyflamend, a unique herbal preparation with nonselective COX inhibitory activity, induces apoptosis of prostate cancer cells that lack COX-2 expression. Nutr Cancer. 2005;52(2):202-12. PMID:
Matti Narkia

Curative Brachytherapy for Recurrent/Residual Tongue Cancer - Entrez PubMed - 0 views

  •  
    Ayukawa F, Shibuya H, Yoshimura RI, Watanabe H, Miura M. Curative Brachytherapy for Recurrent/Residual Tongue Cancer. Strahlenther Onkol. 2007 Mar;183(3):133-137. PMID: 17340071 [PubMed - as supplied by publisher]
Matti Narkia

A pilot clinical study of continuous intravenous a...[P R Health Sci J. 2005] - PubMed ... - 0 views

  •  
    A pilot clinical study of continuous intravenous ascorbate in terminal cancer patients. Riordan HD, Casciari JJ, González MJ, Riordan NH, Miranda-Massari JR, Taylor P, Jackson JA. P R Health Sci J. 2005 Dec;24(4):269-76. PMID: 16570523
Matti Narkia

Intravenous vitamin C as a chemotherapy agent: a r...[P R Health Sci J. 2004] - PubMed ... - 0 views

  •  
    Intravenous vitamin C as a chemotherapy agent: a report on clinical cases.\nRiordan HD, Riordan NH, Jackson JA, Casciari JJ, Hunninghake R, González MJ, Mora EM, Miranda-Massari JR, Rosario N, Rivera A.\nP R Health Sci J. 2004 Jun;23(2):115-8.\nPMID: 15377059
Matti Narkia

Differential effects of selenium on benign and malignant prostate epithelial cells: sti... - 0 views

  •  
    Differential effects of selenium on benign and malignant prostate epithelial cells: stimulation of LNCaP cell growth by noncytotoxic, low selenite concentrations. Kandaş NO, Randolph C, Bosland MC. Nutr Cancer. 2009;61(2):251-64. PMID: 19235042
Matti Narkia

Vitamin D: its role in cancer prevention and treatment - Entrez PubMed - 0 views

  •  
    Holick MF. Vitamin D: its role in cancer prevention and treatment. Prog Biophys Mol Biol. 2006 Sep;92(1):49-59. Epub 2006 Mar 10. Review. PMID: 16566961 [PubMed - indexed for MEDLINE]
Matti Narkia

An estimate of cancer mortality rate reductions in Europe and the US with 1,000 IU of o... - 0 views

  •  
    Grant WB, Garland CF, Gorham ED. An estimate of cancer mortality rate reductions in Europe and the US with 1,000 IU of oral vitamin D per day. Recent Results Cancer Res. 2007;174:225-34. PMID: 17302200 [PubMed - in process]
Matti Narkia

In-vitro effects of polyphenols from cocoa and beta-sitosterol on the growth of human p... - 0 views

  •  
    Jourdain C, Tenca G, Deguercy A, Troplin P, Poelman D. In-vitro effects of polyphenols from cocoa and beta-sitosterol on the growth of human prostate cancer and normal cells. Eur J Cancer Prev. 2006 Aug;15(4):353-61. PMID: 16835506 [PubMed - indexed fo
1 - 20 of 60 Next › Last »
Showing 20 items per page